- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT05114382
An Evaluation of the Safety and Performance of the CathVision Cube® System
연구 개요
상세 설명
A prospective, single center, open-label, single arm study to evaluate the safety and technical performance of the CathVision Cube® system.
Patients undergoing assessment and ablation of cardiac arrhythmias, by Electro Physiology (EP) procedure, and who meet all inclusion criteria will be enrolled in the study and undergo the EP procedure. Intracardiac signals will be passively recorded using the CathVision Cube® System in parallel with a commercial (CE marked) EP recording system and later compared and evaluated. The investigational device will not be used for direct clinical care decisions or therapy. The EP procedure will be guided by the study site Standards Of Care.
연구 유형
등록 (실제)
단계
- 해당 없음
연락처 및 위치
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
- Patient indicated by investigator for catheter ablation or diagnostic electrophysiology procedure.
- Male or non-pregnant female aged ≥18 years. Female patients of childbearing potential must have a negative pregnancy test (per site standard test) within 7 days prior to index procedure.
- Able and willing to directly provide informed consent.
Exclusion Criteria:
- Patient inability to understand or refusal to sign informed consent.
- Pregnant or nursing patients and those who plan pregnancy in the period up to 1 month following the index procedure.
- Current participation in another investigational drug or device study that interferes with this study.
- Patient is a prisoner.
- Patients who in the opinion of the physician are not candidates for this study. Prior atrial septal defect (ASD) or patent foramen ovale (PFO) closure with a device using a transcatheter percutaneous approach.
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 특수 증상
- 할당: 해당 없음
- 중재 모델: 단일 그룹 할당
- 마스킹: 없음(오픈 라벨)
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
---|---|
다른: A prospective, multi-center, open-label, single arm study
Patients undergoing assessment and ablation of cardiac arrhythmiast.
who are scheduled for an electrophysiology (EP) procedure and meet all inclusion criteria will be enrolled in the study and undergo the EP procedure.
Intracardiac signals will be passively recorded using the CathVision Cube® System in parallel with the commercial (CE marked) EP recording system for post procedure evaluation.
The investigational device will not be used for direct clinical care decisions or therapy.
The EP procedure will be guided by the study site Standards Of Care.
|
Intracardiac signals will be passively recorded using CathVision Cube® System in parallel with the commercial (CE marked) EP recording system during a scheduled electrophysiology procedure
다른 이름들:
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
---|---|---|
Freedom from major adverse events, evaluated at hospital discharge.
기간: From EP procedure to hospital discharge is 1 day
|
Freedom from major adverse events, evaluated at hospital discharge
|
From EP procedure to hospital discharge is 1 day
|
Recording low-voltage electrograms
기간: Duration of the EP procedure can take up to 6 hours
|
Recording low-voltage electrograms under 20uV amplitude
|
Duration of the EP procedure can take up to 6 hours
|
The Primary Performance endpoint of study will be evaluated as technical success of CathVision Cube® system to collect and record intracardiac signals during EP procedures
기간: Duration of the EP procedure can take up to 6 hours
|
Logging time for arrhythmia termination / block
|
Duration of the EP procedure can take up to 6 hours
|
Compatibility of Cube System with commercially available 3D mapping system
기간: Duration of the EP procedure can take up to 6 hours
|
Assessing compatibility of Cube System with commercially available 3D mapping system with available intracardiac catheters.
Compatibility is assessed by that the Cube System does not introduce a visual detectable distortion on the commercial available 3D mapping systems
|
Duration of the EP procedure can take up to 6 hours
|
공동 작업자 및 조사자
스폰서
수사관
- 수석 연구원: Josef Kautzner, Prof., IKEM, Prague, Czech Republic
- 수석 연구원: Peter K Jacobsen, MD, DMSc, Righospitalet, Copenhagen, Denmark
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (실제)
연구 완료 (실제)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .
EP Procedure에 대한 임상 시험
-
eXIthera Pharmaceuticals빼는
-
National Institute of Allergy and Infectious Diseases...완전한
-
Region StockholmKarolinska Institutet초대로 등록간질 | 미토콘드리아 질병 | 운동 신경 질환 | 대사 질환 | 론 | 소아 간질
-
John SappNova Scotia Health Authority; Rochester Institute of Technology모병
-
Eupraxia Pharmaceuticals Inc.NBCD A/S완전한
-
Kansas City Heart Rhythm Research Foundation아직 모집하지 않음